Abstract
New advances in diagnostic technologies in nuclear medicine and radiopharmaceutical development, has led to the introduction of some potent copper-radiopharmaceuticals used in the diagnosis and/or therapy of human diseases. Copper radio nuclides provide a series of therapeutic/diagnostic tracers suitable for radiolabeling of small molecules, peptides, antibody fragments and monoclonal antibodies. The current status of copper radiopharmaceuticals for imaging, therapy and research studies of oncological processes is reviewed here with a look into the future directions as the conclusion.
Keywords: Copper radiosiotopes, radiopharmaceuticals, diagnosis, therapy, PET
Current Radiopharmaceuticals
Title: Production and Application of Copper Radiopharmaceuticals
Volume: 2 Issue: 2
Author(s): Amir Reza Jalilian, Pejman Rowshanfarzad and Mahsheed Sabet
Affiliation:
Keywords: Copper radiosiotopes, radiopharmaceuticals, diagnosis, therapy, PET
Abstract: New advances in diagnostic technologies in nuclear medicine and radiopharmaceutical development, has led to the introduction of some potent copper-radiopharmaceuticals used in the diagnosis and/or therapy of human diseases. Copper radio nuclides provide a series of therapeutic/diagnostic tracers suitable for radiolabeling of small molecules, peptides, antibody fragments and monoclonal antibodies. The current status of copper radiopharmaceuticals for imaging, therapy and research studies of oncological processes is reviewed here with a look into the future directions as the conclusion.
Export Options
About this article
Cite this article as:
Jalilian Reza Amir, Rowshanfarzad Pejman and Sabet Mahsheed, Production and Application of Copper Radiopharmaceuticals, Current Radiopharmaceuticals 2009; 2 (2) . https://dx.doi.org/10.2174/1874471010902020092
DOI https://dx.doi.org/10.2174/1874471010902020092 |
Print ISSN 1874-4710 |
Publisher Name Bentham Science Publisher |
Online ISSN 1874-4729 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Novobiocin and Additional Inhibitors of the Hsp90 C-Terminal Nucleotide- binding Pocket
Current Medicinal Chemistry The Oncogenic Functions of Insulin-like Growth Factor 2 mRNA-Binding Protein 3 in Human Carcinomas
Current Pharmaceutical Design Recent Developments in the Synthesis of Antitumor-active Glycyrrhetinic Acid Derivatives
Mini-Reviews in Organic Chemistry Rational Targeting of Peroxisome Proliferating Activated Receptor Subtypes
Current Medicinal Chemistry Interactions between Drugs and Surgery in the Treatment of LUTS and Advanced Renal Cancer
Current Drug Targets Cancer Drug Development with the Help of Radiopharmaceuticals: Academic Experience
Current Pharmaceutical Design Rapid Nucleic Acid Reaction Circuits for Point-of-care Diagnosis of Diseases
Current Topics in Medicinal Chemistry TRIP13 Activates Glycolysis to Promote Cell Stemness and Strengthen Doxorubicin Resistance of Colorectal Cancer Cells
Current Medicinal Chemistry Key Epigenetic Events Involved in the Maintenance of Breast Cancer Stem Cells
Current Stem Cell Research & Therapy The Adrenergic System in Gastrointestinal Cancers
Current Cancer Therapy Reviews DTCM-glutarimide Delays Growth and Radiosensitizes Glioblastoma
Anti-Cancer Agents in Medicinal Chemistry Gene Therapy of Chronic Pain
Current Gene Therapy Molecular Architecture of Tumor Suppressor p53
Current Topics in Medicinal Chemistry Computed Tomographic Evaluation of Colonic Diverticulum Complications
Current Medical Imaging Insulin-like Effects of Mt. Fuji Subsoil Water which Conta ins Vanadium on Cultured Cells: Insight from Japan
Current Traditional Medicine Should we Target Allergen Protease Activity to Decrease the Burden of Allergic Airway Inflammation?
Inflammation & Allergy - Drug Targets (Discontinued) Specific Targeting of HER2-Positive Head and Neck Squamous Cell Carcinoma Line HN5 by Idarubicin-ZHER2 Affibody Conjugate
Current Cancer Drug Targets The Application of Photofrin II® as a Sensitizing Agent for Ionizing Radiation-A New Approach in Tumor Therapy?
Current Medicinal Chemistry Imaging Virus-Associated Cancer
Current Pharmaceutical Design Oxidative Stress and Antioxidants in Neurological Diseases: Is There Still Hope?
Current Drug Targets